查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球磊晶市场：市场规模、份额、趋势分析、机会和预测（2019-2030）
市场调查报告书
商品编码
1410997

全球磊晶市场：市场规模、份额、趋势分析、机会和预测（2019-2030）

Epigenetics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Product ; By Technology ; By Application ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球磊晶市场规模预计将以 15.2% 的复合年增长率增长一倍以上，到 2030 年达到 54.7 亿美元。

报告显示，由于人们越来越关注癌症盛行率上升的治疗和管理、医疗保健领域研发活动的加强以及个人化医疗范围的扩大，全球磊晶市场正在蓬勃发展。

领先的策略咨询和市场研究公司 BlueWeave Consulting 在最近的一项研究中估计，2023 年全球磊晶市场规模将达到 23.4 亿美元。 BlueWeave 预测，在 2024 年至 2030 年的预测期内，全球磊晶市场规模将以 15.20% 的复合年增长率成长，到 2030 年将达到 54.7 亿美元。包括癌症和心血管疾病在内的慢性病盛行率不断上升，以及药物研发的不断增加是全球磊晶市场的关键驱动力。此外，在整个预测期内，对标靶药物开发和客製化医疗的日益重视预计将为全球磊晶市场的参与者提供重大机会。

该报告的详细分析提供了有关成长潜力、未来趋势和全球磊晶市场的资讯。它还重点关注推动市场总规模预测的因素。该报告致力于提供全球磊晶市场的最新技术趋势和产业见解，以帮助决策者做出明智的策略决策。此外，我们也分析了市场的成长动力、挑战和竞争力。

目录

第一章 研究框架

第 2 章执行摘要

第三章全球磊晶市场洞察

  • 产业价值链分析
  • DROC分析
    • 生长促进因子
      • 慢性病盛行率上升
      • 磊晶技术的进展
      • 增加磊晶研究的投资
    • 抑制因素
      • 资料隐私问题
      • 磊晶技术的成本
    • 机会
      • 个人化医疗的发展
      • 新应用的开发
    • 任务
      • 监管障碍
      • 缺乏标准化
  • 科技进步/最新发展
  • 消费者行为与洞察
  • 法律规范
  • 波特五力分析

第四章全球磊晶市场概述

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
      • 试剂
      • 套件
      • 晶片测序套件
      • 全基因组扩增套件
      • 亚硫酸氢盐转换套件
      • RNA定序试剂套件
      • 其他的
      • 装置
      • 酵素
      • 服务
    • 依技术
      • DNA甲基化
      • 组蛋白甲基化
      • 组蛋白乙酰化
      • 大非编码RNA
      • 微小RNA修饰
      • 染色质结构
    • 按用途
      • 肿瘤学
      • 固态肿瘤
      • 液体肿瘤
      • 非肿瘤学
      • 发炎疾病
      • 代谢性疾病
      • 感染疾病
      • 心血管疾病
      • 其他的
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区 (APAC)
      • 拉丁美洲 (LATAM)
      • 中东和非洲 (MEA)

第五章北美磊晶市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 依技术
    • 按用途
    • 按国家/地区
      • 美国
      • 加拿大

第六章欧洲磊晶市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 依技术
    • 按用途
    • 按国家/地区
      • 德国
      • 英国
      • 义大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 其他欧洲国家

第七章亚太表观磊晶市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 依技术
    • 按用途
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳洲和纽西兰
      • 印尼
      • 马来西亚
      • 新加坡
      • 越南
      • 其他亚太地区

第八章拉丁美洲磊晶市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 依技术
    • 按用途
    • 按国家/地区
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 其他拉丁美洲

第九章中东和非洲磊晶市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 依技术
    • 按用途
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 科威特
      • 南非
      • 奈及利亚
      • 阿尔及利亚
      • 其他中东/非洲

第10章竞争形势

  • 主要企业及其产品列表
  • 2023 年全球磊晶市场占有率分析
  • 透过管理参数进行竞争基准化分析
  • 主要策略发展（合併、收购、合作伙伴关係等）

第十一章地缘政治紧张局势加剧对全球磊晶市场的影响

第十二章 公司简介（公司简介、财务矩阵、竞争形势、关键人力资源、主要竞争对手、联络地址、策略展望、SWOT分析）

  • Qiagen
  • Thermo Fisher Scientific
  • Illumina
  • Agilent Technologies
  • Zymo Research
  • Clontech
  • New England Biolabs（NEB）
  • EpigenTek Group Inc.
  • Active Motif
  • Diagenode
  • 其他主要企业

第十三章 主要战略建议

第14章调查方法

简介目录
Product Code: BWC24035

Global Epigenetics Market Size More Than Doubles at Robust CAGR of 15.2%, to Reach USD 5.47 Billion by 2030.

Global Epigenetics Market is flourishing because of and increasing focus on the treatment and management of rising prevalence of cancer and intensifying R&D activities in the healthcare sector, along with expanding scope of personalized medicine.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Epigenetics Market size at USD 2.34 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Epigenetics Market size to expand at a CAGR of 15.20% reaching a value of USD 5.47 billion by 2030. The growing prevalence of chronic illnesses, including cancer and cardiovascular diseases, as well as an increase in pharmaceutical research and development are significant driving factors for the Global Epigenetics Market. Moreover, throughout the projected period, the development of targeted medicines and a growing emphasis on customized medicine are expected to provide substantial opportunities for players in the Global Epigenetic Market.

Opportunity: Advanced research and development activities

With the rising prevalence of various chronic diseases, various pharmaceutical and biotechnology companies are increasing their investments in R&D programs to make advancements in epigenetics and expand its application in non-oncology segments as well. A recent study published in the scientific journal Nature explores the epigenetic changes in cancer progression as well as identifies the cellular pathways of these genes that may potentially prove crucial in developing strategies for maximizing the therapeutic benefits while minimizing the side effects. Positive outcomes from research and development activities are anticipated to provide lucrative growth opportunities for companies in the Global Epigenetics Market over the forecast period.

Impact of Escalating Geopolitical Tensions on Global Epigenetics Market

The escalating geopolitical tensions hampered the growth of the global epigenetics market. For instance, Ukraine is one of the leading healthcare providers and engages in extensive research and development activities. However, after Russia attacked Ukraine in February 2022, the healthcare and clinical infrastructure of Ukraine were impacted. Patients from abroad as well as those within Ukraine experienced difficulties accessing healthcare resources due to the regional unrest in the country, especially in the Kyiv region. Research collaborations and international partnerships in clinical research may be put under pressure after the situation in Ukraine, which might impede advancements in the sector. Essentially, these geopolitical tensions highlight the necessity for strategic adaptability and resilience in navigating these challenging conditions by introducing uncertainties and obstacles across all aspects of the epigenetics business.

Global Epigenetics Market

Segmental Coverage

Global Epigenetics Market - By Technology

Based on technology, the Global Epigenetics Market is segmented into DNA Methylation, Histone Methylation, Histone Acetylation, Large Non-Coding RNA, MicroRNA Modification, and Chromatin Structures. DNA methylation technology holds the largest share in the Global Epigenetics Market. According to a report published in The Lancet, with tissue-specific variations, methylation may be utilized in a basic cell-free circulating-DNA blood test to identify cell death and track several prevalent diseases. Additionally, it demonstrates the enormous potential for disease diagnosis, customized treatment, and prevention.

Global Epigenetics Market - By Region

The in-depth research report on the Global Epigenetics Market covers the market in a major number of countries across five regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Epigenetics Market. Accessible healthcare services, along with advanced medical infrastructure, act as a major driving factor for market growth in the region. Moreover, extensive research and development activities surrounding epigenetics, owing to the high concentration of leading pharmaceutical companies and favorable government support, contribute to the epigenetics market growth in North America.

Competitive Landscape

Major players operating in the Global Epigenetics Market include: Qiagen, Thermo Fisher Scientific, Illumina, Agilent Technologies, Zymo Research, Clontech, New England Biolabs (NEB), EpigenTek Group Inc., Active Motif, and Diagenode. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Epigenetics Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Epigenetics Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Epigenetics Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Rising Prevalence of Chronic Diseases
      • 3.2.1.2. Advances in Epigenetic Technologies
      • 3.2.1.3. Increasing Investment in Epigenetics Research
    • 3.2.2. Restraints
      • 3.2.2.1. Data Privacy Concerns
      • 3.2.2.2. Cost of Epigenetic Technologies
    • 3.2.3. Opportunities
      • 3.2.3.1. Development of Personalized Medicine
      • 3.2.3.2. Expansion into New Applications
    • 3.2.4. Challenges
      • 3.2.4.1. Regulatory Hurdles
      • 3.2.4.2. Lack of Standardization
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Consumer Behavior and Insights
  • 3.5. Regulatory Framework
  • 3.6. Porter's Five Forces Analysis
    • 3.6.1. Bargaining Power of Suppliers
    • 3.6.2. Bargaining Power of Buyers
    • 3.6.3. Threat of New Entrants
    • 3.6.4. Threat of Substitutes
    • 3.6.5. Intensity of Rivalry

4. Global Epigenetics Market Overview

  • 4.1. Market Size & Forecast, 2019-2030
    • 4.1.1. By Value (USD Billion)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Reagents
      • 4.2.1.2. Kits
      • 4.2.1.2.1. Chip Sequencing Kit
      • 4.2.1.2.2. Whole Genomic Amplification Kit
      • 4.2.1.2.3. Bisulfite Conversion Kit
      • 4.2.1.2.4. RNA Sequencing Kit
      • 4.2.1.2.5. Others
      • 4.2.1.3. Instruments
      • 4.2.1.4. Enzymes
      • 4.2.1.5. Services
    • 4.2.2. By Technology
      • 4.2.2.1. DNA Methylation
      • 4.2.2.2. Histone Methylation
      • 4.2.2.3. Histone Acetylation
      • 4.2.2.4. Large Non - Coding RNA
      • 4.2.2.5. MicroRNA Modification
      • 4.2.2.6. Chromatin Structures
    • 4.2.3. By Application
      • 4.2.3.1. Oncology
      • 4.2.3.1.1. Solid Tumors
      • 4.2.3.1.2. Liquid Tumors
      • 4.2.3.2. Non - Oncology
      • 4.2.3.2.1. Inflammatory Diseases
      • 4.2.3.2.2. Metabolic Diseases
      • 4.2.3.2.3. Infectious Diseases
      • 4.2.3.2.4. Cardiovascular Diseases
      • 4.2.3.2.5. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Epigenetics Market

  • 5.1. Market Size & Forecast, 2019-2030
    • 5.1.1. By Value (USD Billion)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By Technology
    • 5.2.3. By Application
    • 5.2.4. By Country
      • 5.2.4.1. United States
      • 5.2.4.1.1. By Product
      • 5.2.4.1.2. By Technology
      • 5.2.4.1.3. By Application
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By Product
      • 5.2.4.2.2. By Technology
      • 5.2.4.2.3. By Application

6. Europe Epigenetics Market

  • 6.1. Market Size & Forecast, 2019-2030
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technology
    • 6.2.3. By Application
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By Product
      • 6.2.4.1.2. By Technology
      • 6.2.4.1.3. By Application
      • 6.2.4.2. United Kingdom
      • 6.2.4.2.1. By Product
      • 6.2.4.2.2. By Technology
      • 6.2.4.2.3. By Application
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By Product
      • 6.2.4.3.2. By Technology
      • 6.2.4.3.3. By Application
      • 6.2.4.4. France
      • 6.2.4.4.1. By Product
      • 6.2.4.4.2. By Technology
      • 6.2.4.4.3. By Application
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By Product
      • 6.2.4.5.2. By Technology
      • 6.2.4.5.3. By Application
      • 6.2.4.6. Belgium
      • 6.2.4.6.1. By Product
      • 6.2.4.6.2. By Technology
      • 6.2.4.6.3. By Application
      • 6.2.4.7. Russia
      • 6.2.4.7.1. By Product
      • 6.2.4.7.2. By Technology
      • 6.2.4.7.3. By Application
      • 6.2.4.8. The Netherlands
      • 6.2.4.8.1. By Product
      • 6.2.4.8.2. By Technology
      • 6.2.4.8.3. By Application
      • 6.2.4.9. Rest of Europe
      • 6.2.4.9.1. By Product
      • 6.2.4.9.2. By Technology
      • 6.2.4.9.3. By Application

7. Asia Pacific Epigenetics Market

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By Product
      • 7.2.4.1.2. By Technology
      • 7.2.4.1.3. By Application
      • 7.2.4.2. India
      • 7.2.4.2.1. By Product
      • 7.2.4.2.2. By Technology
      • 7.2.4.2.3. By Application
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By Product
      • 7.2.4.3.2. By Technology
      • 7.2.4.3.3. By Application
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By Product
      • 7.2.4.4.2. By Technology
      • 7.2.4.4.3. By Application
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By Product
      • 7.2.4.5.2. By Technology
      • 7.2.4.5.3. By Application
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By Product
      • 7.2.4.6.2. By Technology
      • 7.2.4.6.3. By Application
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By Product
      • 7.2.4.7.2. By Technology
      • 7.2.4.7.3. By Application
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By Product
      • 7.2.4.8.2. By Technology
      • 7.2.4.8.3. By Application
      • 7.2.4.9. Vietnam
      • 7.2.4.9.1. By Product
      • 7.2.4.9.2. By Technology
      • 7.2.4.9.3. By Application
      • 7.2.4.10. Rest of APAC
      • 7.2.4.10.1. By Product
      • 7.2.4.10.2. By Technology
      • 7.2.4.10.3. By Application

8. Latin America Epigenetics Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By Product
      • 8.2.4.1.2. By Technology
      • 8.2.4.1.3. By Application
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By Product
      • 8.2.4.2.2. By Technology
      • 8.2.4.2.3. By Application
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By Product
      • 8.2.4.3.2. By Technology
      • 8.2.4.3.3. By Application
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By Product
      • 8.2.4.4.2. By Technology
      • 8.2.4.4.3. By Application
      • 8.2.4.5. Rest of LATAM
      • 8.2.4.5.1. By Product
      • 8.2.4.5.2. By Technology
      • 8.2.4.5.3. By Application

9. Middle East & Africa Epigenetics Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By Product
      • 9.2.4.1.2. By Technology
      • 9.2.4.1.3. By Application
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By Product
      • 9.2.4.2.2. By Technology
      • 9.2.4.2.3. By Application
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By Product
      • 9.2.4.3.2. By Technology
      • 9.2.4.3.3. By Application
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By Product
      • 9.2.4.4.2. By Technology
      • 9.2.4.4.3. By Application
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By Product
      • 9.2.4.5.2. By Technology
      • 9.2.4.5.3. By Application
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By Product
      • 9.2.4.6.2. By Technology
      • 9.2.4.6.3. By Application
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By Product
      • 9.2.4.7.2. By Technology
      • 9.2.4.7.3. By Application
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By Product
      • 9.2.4.8.2. By Technology
      • 9.2.4.8.3. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Epigenetics Market Share Analysis, 2023
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Escalating Geopolitical Tensions on Global Epigenetics Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 12.1. Qiagen
  • 12.2. Thermo Fisher Scientific
  • 12.3. Illumina
  • 12.4. Agilent Technologies
  • 12.5. Zymo Research
  • 12.6. Clontech
  • 12.7. New England Biolabs (NEB)
  • 12.8. EpigenTek Group Inc.
  • 12.9. Active Motif
  • 12.10. Diagenode
  • 12.11. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations